Cai C, Zhang N, Wang M, Wang L, Zhao H, Zhang X
Front Oncol. 2024; 14:1448219.
PMID: 39421450
PMC: 11484443.
DOI: 10.3389/fonc.2024.1448219.
Deng H, Wang L, Li Z, Zhan T, Huang L
BMC Cancer. 2024; 24(1):948.
PMID: 39095810
PMC: 11297620.
DOI: 10.1186/s12885-024-12682-z.
Xu K, Gao J, Feng L, Fang Y, Tang X
Front Immunol. 2023; 14:1203876.
PMID: 37292208
PMC: 10244673.
DOI: 10.3389/fimmu.2023.1203876.
Bonis A, DellAmore A, Verzeletti V, Melan L, Zambello G, Nardocci C
J Clin Med. 2023; 12(4).
PMID: 36835946
PMC: 9964907.
DOI: 10.3390/jcm12041411.
Xu S, Zhang X, Jiang Q, Chen M, He M, Shen P
World J Clin Cases. 2022; 10(28):10236-10243.
PMID: 36246828
PMC: 9561556.
DOI: 10.12998/wjcc.v10.i28.10236.
Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.
Chen Z, Ding C, Zhang T, He Y, Jiang G
Onco Targets Ther. 2022; 15:609-627.
PMID: 35676912
PMC: 9167841.
DOI: 10.2147/OTT.S364465.
Hepatoid Adenocarcinoma of the Lung.
Li M, Fan Y, Lu H
Technol Cancer Res Treat. 2021; 20:15330338211057983.
PMID: 34816785
PMC: 8646196.
DOI: 10.1177/15330338211057983.
Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.
Hou Z, Xie J, Zhang L, Dai G, Chen Y, He L
Front Oncol. 2021; 11:702216.
PMID: 34422656
PMC: 8377348.
DOI: 10.3389/fonc.2021.702216.
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Mao J, Liu C, Zhao Y, Ding G, Ma J, Teng F
Am J Transl Res. 2021; 13(3):898-922.
PMID: 33841629
PMC: 8014347.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Lei L, Yang L, Xu Y, Chen H, Zhan P, Wang W
Open Med (Wars). 2021; 16(1):169-174.
PMID: 33585692
PMC: 7863000.
DOI: 10.1515/med-2021-0215.
Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma.
Miyama Y, Fujii T, Murase K, Takaya H, Kondo F
Autops Case Rep. 2020; 10(2):e2020162.
PMID: 33344280
PMC: 7703083.
DOI: 10.4322/acr.2020.162.
Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable -Positive Hepatoid Lung Adenocarcinoma: A Case Report and Literature Review.
Chen L, Han X, Gao Y, Zhao Q, Wang Y, Jiang Y
Onco Targets Ther. 2020; 13:4359-4364.
PMID: 32547068
PMC: 7245476.
DOI: 10.2147/OTT.S248226.
Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
Li J, Qi H, Xu B, Zhao J, Gao H, Ma X
Front Oncol. 2020; 9:1360.
PMID: 31921629
PMC: 6917606.
DOI: 10.3389/fonc.2019.01360.
Hepatoid adenocarcinoma of the lung.
Cavalcante L, Felipe-Silva A, de Campos F, Martines J
Autops Case Rep. 2019; 3(1):5-14.
PMID: 31528592
PMC: 6671883.
DOI: 10.4322/acr.2013.002.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Yang K, Jiang H, Li Q
Medicine (Baltimore). 2019; 98(14):e15053.
PMID: 30946350
PMC: 6455993.
DOI: 10.1097/MD.0000000000015053.
Primary hepatoid adenocarcinoma of the orbit.
Alsberge J, Grumbine F, Bloomer M, Vagefi M, Kersten R
Am J Ophthalmol Case Rep. 2018; 5:38-40.
PMID: 29503944
PMC: 5757757.
DOI: 10.1016/j.ajoc.2016.10.006.
Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.
Sun J, Zhang B, Li L, Yu H, Wang B
Oncol Lett. 2016; 12(1):189-194.
PMID: 27347123
PMC: 4906620.
DOI: 10.3892/ol.2016.4559.
Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes.
Xiao C, Wu F, Jiang H, Teng L, Song F, Wang Q
Oncol Lett. 2015; 10(3):1605-1609.
PMID: 26622718
PMC: 4533739.
DOI: 10.3892/ol.2015.3430.
Hepatoid adenocarcinoma of the lung: a case report and review of the literature.
Shaib W, Sharma R, Mosunjac M, Farris 3rd A, El Rayes B
J Gastrointest Cancer. 2014; 45 Suppl 1:99-102.
PMID: 24408270
DOI: 10.1007/s12029-013-9558-7.